1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Cowburn, D.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.00
90.00
90.00
1.000
1.000
1.000
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
UK
Structure
STRUE6
2005
0969-2126
3
1075
1086
10.1016/S0969-2126(01)00243-X
8590002
The solution structure of Abl SH3, and its relationship to SH2 in the SH(32) construct.
1995
US
Mol.Cell.Biol.
MCEBD4
2044
0270-7306
14
2883
Mutagenic Analysis of the Roles of Sh2 and SH3 Domains in Regulation of the Abl Tyrosine Kinase
1994
US
Nat.Struct.Biol.
NSBIEW
2024
1072-8368
1
546
High-Resolution Crystal Structures of Tyrosine Kinase SH3 Domains Complexed with Proline-Rich Peptides
1994
US
Science
SCIEAS
0038
0036-8075
259
1157
Identification of a Ten-Amino Acid Proline-Rich SH3 Binding Site
1993
UK
Embo J.
EMJODG
0897
0261-4189
12
2617
Crystal Structure of the SH3 Domain in Human Fyn; Comparison of the Three-Dimensional Structures of SH3 Domains in Tyrosine Kinases and Spectrin
1993
US
Cell(Cambridge,Mass.)
CELLB5
0998
0092-8674
70
697
Three-Dimensional Solution Structure of the Src Homology 2 Domain of C-Abl
1992
UK
Nature
NATUAS
0006
0028-0836
359
851
Crystal Structure of a Src-Homology 3 (SH3) Domain
1992
10.2210/pdb1awo/pdb
pdb_00001awo
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
6637.299
ABL TYROSINE KINASE
2.7.1.112
SRC-HOMOLOGY 3 (SH3) DOMAIN
N64S, N120S
1
man
polymer
no
no
GSPGGSLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVS
GSPGGSLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVS
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
human
Homo
Escherichia
sample
EXPRESSED AS GST FUSIONS AND CLEAVED
9606
Homo sapiens
562
Escherichia coli
NB42
PGEX
database_2
pdbx_database_status
pdbx_struct_assembly
pdbx_struct_oper_list
struct_ref_seq_dif
repository
Initial release
Version format compliance
Version format compliance
Database references
Derived calculations
Other
1
0
1998-01-28
1
1
2008-03-27
1
2
2011-07-13
1
3
2022-02-16
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_pdbx_database_status.process_site
_struct_ref_seq_dif.details
Y
BNL
1997-10-03
REL
LOWEST TARGET FUNCTION
100
20
HMQX
HTQC
H/13C HSQC
1H-13C HQQC
NOESY
NOESY-HMQC
J-HMQC
EXCHANGE
15N{1H NOE
7.5
298
K
USED REDAC STRATEGY
VARIABLE TARGET FUNCTION TORSION ANGLE SIMULATED ANNEALING
WUTHRICH
refinement
DIANA
2.1
structure solution
RUNMR
structure solution
UXNMR
structure solution
DIANA (REDAC)
(REDAC)
500
GE
GE OMEGA 400
500
Bruker
DMX-600
n
1
59
A
n
2
60
A
n
3
61
A
n
4
62
A
n
5
63
A
SER
64
n
6
SER
64
A
LEU
65
n
7
LEU
65
A
PHE
66
n
8
PHE
66
A
VAL
67
n
9
VAL
67
A
ALA
68
n
10
ALA
68
A
LEU
69
n
11
LEU
69
A
TYR
70
n
12
TYR
70
A
ASP
71
n
13
ASP
71
A
PHE
72
n
14
PHE
72
A
VAL
73
n
15
VAL
73
A
ALA
74
n
16
ALA
74
A
SER
75
n
17
SER
75
A
GLY
76
n
18
GLY
76
A
ASP
77
n
19
ASP
77
A
ASN
78
n
20
ASN
78
A
THR
79
n
21
THR
79
A
LEU
80
n
22
LEU
80
A
SER
81
n
23
SER
81
A
ILE
82
n
24
ILE
82
A
THR
83
n
25
THR
83
A
LYS
84
n
26
LYS
84
A
GLY
85
n
27
GLY
85
A
GLU
86
n
28
GLU
86
A
LYS
87
n
29
LYS
87
A
LEU
88
n
30
LEU
88
A
ARG
89
n
31
ARG
89
A
VAL
90
n
32
VAL
90
A
LEU
91
n
33
LEU
91
A
GLY
92
n
34
GLY
92
A
TYR
93
n
35
TYR
93
A
ASN
94
n
36
ASN
94
A
HIS
95
n
37
HIS
95
A
ASN
96
n
38
ASN
96
A
GLY
97
n
39
GLY
97
A
GLU
98
n
40
GLU
98
A
TRP
99
n
41
TRP
99
A
CYS
100
n
42
CYS
100
A
GLU
101
n
43
GLU
101
A
ALA
102
n
44
ALA
102
A
GLN
103
n
45
GLN
103
A
THR
104
n
46
THR
104
A
LYS
105
n
47
LYS
105
A
ASN
106
n
48
ASN
106
A
GLY
107
n
49
GLY
107
A
GLN
108
n
50
GLN
108
A
GLY
109
n
51
GLY
109
A
TRP
110
n
52
TRP
110
A
VAL
111
n
53
VAL
111
A
PRO
112
n
54
PRO
112
A
SER
113
n
55
SER
113
A
ASN
114
n
56
ASN
114
A
TYR
115
n
57
TYR
115
A
ILE
116
n
58
ILE
116
A
THR
117
n
59
THR
117
A
PRO
118
n
60
PRO
118
A
VAL
119
n
61
VAL
119
A
SER
120
n
62
SER
120
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
A
O
VAL
67
A
O
VAL
9
A
N
THR
117
A
N
THR
59
A
O
GLY
109
A
O
GLY
51
A
N
ALA
102
A
N
ALA
44
A
O
GLU
101
A
O
GLU
43
A
N
GLY
92
A
N
GLY
34
1
A
GLY
59
A
GLY
1
1
Y
1
A
SER
60
A
SER
2
1
Y
1
A
PRO
61
A
PRO
3
1
Y
1
A
GLY
62
A
GLY
4
1
Y
1
A
GLY
63
A
GLY
5
1
Y
2
A
GLY
59
A
GLY
1
1
Y
2
A
SER
60
A
SER
2
1
Y
2
A
PRO
61
A
PRO
3
1
Y
2
A
GLY
62
A
GLY
4
1
Y
2
A
GLY
63
A
GLY
5
1
Y
3
A
GLY
59
A
GLY
1
1
Y
3
A
SER
60
A
SER
2
1
Y
3
A
PRO
61
A
PRO
3
1
Y
3
A
GLY
62
A
GLY
4
1
Y
3
A
GLY
63
A
GLY
5
1
Y
4
A
GLY
59
A
GLY
1
1
Y
4
A
SER
60
A
SER
2
1
Y
4
A
PRO
61
A
PRO
3
1
Y
4
A
GLY
62
A
GLY
4
1
Y
4
A
GLY
63
A
GLY
5
1
Y
5
A
GLY
59
A
GLY
1
1
Y
5
A
SER
60
A
SER
2
1
Y
5
A
PRO
61
A
PRO
3
1
Y
5
A
GLY
62
A
GLY
4
1
Y
5
A
GLY
63
A
GLY
5
1
Y
6
A
GLY
59
A
GLY
1
1
Y
6
A
SER
60
A
SER
2
1
Y
6
A
PRO
61
A
PRO
3
1
Y
6
A
GLY
62
A
GLY
4
1
Y
6
A
GLY
63
A
GLY
5
1
Y
7
A
GLY
59
A
GLY
1
1
Y
7
A
SER
60
A
SER
2
1
Y
7
A
PRO
61
A
PRO
3
1
Y
7
A
GLY
62
A
GLY
4
1
Y
7
A
GLY
63
A
GLY
5
1
Y
8
A
GLY
59
A
GLY
1
1
Y
8
A
SER
60
A
SER
2
1
Y
8
A
PRO
61
A
PRO
3
1
Y
8
A
GLY
62
A
GLY
4
1
Y
8
A
GLY
63
A
GLY
5
1
Y
9
A
GLY
59
A
GLY
1
1
Y
9
A
SER
60
A
SER
2
1
Y
9
A
PRO
61
A
PRO
3
1
Y
9
A
GLY
62
A
GLY
4
1
Y
9
A
GLY
63
A
GLY
5
1
Y
10
A
GLY
59
A
GLY
1
1
Y
10
A
SER
60
A
SER
2
1
Y
10
A
PRO
61
A
PRO
3
1
Y
10
A
GLY
62
A
GLY
4
1
Y
10
A
GLY
63
A
GLY
5
1
Y
11
A
GLY
59
A
GLY
1
1
Y
11
A
SER
60
A
SER
2
1
Y
11
A
PRO
61
A
PRO
3
1
Y
11
A
GLY
62
A
GLY
4
1
Y
11
A
GLY
63
A
GLY
5
1
Y
12
A
GLY
59
A
GLY
1
1
Y
12
A
SER
60
A
SER
2
1
Y
12
A
PRO
61
A
PRO
3
1
Y
12
A
GLY
62
A
GLY
4
1
Y
12
A
GLY
63
A
GLY
5
1
Y
13
A
GLY
59
A
GLY
1
1
Y
13
A
SER
60
A
SER
2
1
Y
13
A
PRO
61
A
PRO
3
1
Y
13
A
GLY
62
A
GLY
4
1
Y
13
A
GLY
63
A
GLY
5
1
Y
14
A
GLY
59
A
GLY
1
1
Y
14
A
SER
60
A
SER
2
1
Y
14
A
PRO
61
A
PRO
3
1
Y
14
A
GLY
62
A
GLY
4
1
Y
14
A
GLY
63
A
GLY
5
1
Y
15
A
GLY
59
A
GLY
1
1
Y
15
A
SER
60
A
SER
2
1
Y
15
A
PRO
61
A
PRO
3
1
Y
15
A
GLY
62
A
GLY
4
1
Y
15
A
GLY
63
A
GLY
5
1
Y
16
A
GLY
59
A
GLY
1
1
Y
16
A
SER
60
A
SER
2
1
Y
16
A
PRO
61
A
PRO
3
1
Y
16
A
GLY
62
A
GLY
4
1
Y
16
A
GLY
63
A
GLY
5
1
Y
17
A
GLY
59
A
GLY
1
1
Y
17
A
SER
60
A
SER
2
1
Y
17
A
PRO
61
A
PRO
3
1
Y
17
A
GLY
62
A
GLY
4
1
Y
17
A
GLY
63
A
GLY
5
1
Y
18
A
GLY
59
A
GLY
1
1
Y
18
A
SER
60
A
SER
2
1
Y
18
A
PRO
61
A
PRO
3
1
Y
18
A
GLY
62
A
GLY
4
1
Y
18
A
GLY
63
A
GLY
5
1
Y
19
A
GLY
59
A
GLY
1
1
Y
19
A
SER
60
A
SER
2
1
Y
19
A
PRO
61
A
PRO
3
1
Y
19
A
GLY
62
A
GLY
4
1
Y
19
A
GLY
63
A
GLY
5
1
Y
20
A
GLY
59
A
GLY
1
1
Y
20
A
SER
60
A
SER
2
1
Y
20
A
PRO
61
A
PRO
3
1
Y
20
A
GLY
62
A
GLY
4
1
Y
20
A
GLY
63
A
GLY
5
1
Y
3
A
A
HB3
CZ
SER
PHE
64
66
1.59
4
A
A
H
O
VAL
THR
67
117
1.59
5
A
A
O
H
ASN
TRP
78
110
1.59
6
A
A
H
O
THR
GLY
104
107
1.60
7
A
A
HG
HG12
SER
VAL
64
119
0.93
7
A
A
HD21
O
ASN
TRP
94
99
1.47
7
A
A
HG
CG1
SER
VAL
64
119
1.47
7
A
A
OG
CG1
SER
VAL
64
119
2.10
8
A
A
HG
CE1
SER
PHE
64
66
0.70
8
A
A
HG
HE1
SER
PHE
64
66
1.01
8
A
A
OG
HE1
SER
PHE
64
66
1.11
8
A
A
HG
CZ
SER
PHE
64
66
1.13
8
A
A
OG
CE1
SER
PHE
64
66
1.20
8
A
A
OG
CZ
SER
PHE
64
66
1.73
8
A
A
CB
CZ
SER
PHE
64
66
1.94
9
A
A
HG
CE1
SER
PHE
64
66
0.76
9
A
A
HG
CZ
SER
PHE
64
66
1.08
9
A
A
HG
HE1
SER
PHE
64
66
1.10
9
A
A
OG
CE1
SER
PHE
64
66
1.36
9
A
A
OG
HE1
SER
PHE
64
66
1.43
9
A
A
OG
CZ
SER
PHE
64
66
1.79
9
A
A
CB
CZ
SER
PHE
64
66
2.05
14
A
A
HD21
O
ASN
TRP
94
99
1.50
19
A
A
HD21
O
ASN
TRP
94
99
1.47
19
A
A
H
O
THR
GLY
104
107
1.58
1
A
LEU
69
-113.13
-79.30
1
A
SER
75
-149.10
-57.95
1
A
ASN
78
-163.47
-43.45
1
A
ASN
96
-176.99
-175.38
1
A
GLU
98
-120.31
-66.90
2
A
LEU
69
-101.62
-81.66
2
A
ASP
77
-46.04
170.27
2
A
ASN
78
-39.30
110.74
2
A
LYS
84
-68.39
-177.36
2
A
LYS
87
-69.29
70.30
2
A
ASN
94
-69.63
-74.82
2
A
HIS
95
165.69
-67.26
3
A
ALA
74
-48.07
94.26
3
A
ASP
77
-112.80
52.01
3
A
ASN
78
168.01
41.86
3
A
LYS
84
-58.07
-175.30
3
A
LYS
87
-69.11
80.83
3
A
HIS
95
-38.35
-80.44
4
A
LEU
69
-83.35
-76.41
4
A
VAL
73
-105.25
-151.91
4
A
ALA
74
-44.82
164.03
4
A
ASP
77
66.78
-165.28
4
A
LYS
84
-57.96
178.56
4
A
HIS
95
154.13
170.23
4
A
ASN
96
41.12
28.92
4
A
GLU
98
-102.66
-63.16
5
A
ALA
74
-55.25
100.19
5
A
ASN
78
79.12
-0.47
5
A
LYS
87
-69.81
90.07
5
A
HIS
95
37.51
41.40
5
A
ASN
96
177.65
169.15
6
A
LEU
69
-90.74
-80.80
6
A
SER
75
-149.73
-67.41
6
A
VAL
119
-77.80
-111.28
7
A
ASP
77
-106.69
-68.71
7
A
LYS
87
-69.32
81.48
7
A
ASN
94
-71.16
-151.55
7
A
ASN
96
-84.72
45.20
7
A
VAL
119
-69.05
-103.41
8
A
LEU
69
-77.80
-77.66
8
A
ASP
77
-166.86
85.47
8
A
ASN
78
38.99
68.29
8
A
LYS
84
-62.25
-176.22
8
A
HIS
95
-91.21
41.73
8
A
ASN
96
-168.80
-53.39
8
A
ASN
106
-150.16
58.71
9
A
LEU
65
-110.64
64.47
9
A
ASP
77
-64.14
-167.02
9
A
ASN
78
-43.06
101.84
9
A
LYS
84
-65.36
-177.81
9
A
HIS
95
37.97
44.41
9
A
ASN
96
176.74
166.83
9
A
GLU
98
-120.32
-63.04
10
A
LEU
69
-95.79
-65.30
10
A
SER
75
-150.00
-65.79
10
A
LYS
84
-62.71
-178.17
10
A
HIS
95
-38.74
-73.97
10
A
GLU
98
-120.34
-52.13
10
A
VAL
119
-101.24
-107.76
11
A
LEU
69
-95.35
-77.04
11
A
SER
75
-148.60
-66.64
11
A
ASP
77
-58.76
173.30
11
A
ASN
78
39.17
82.46
11
A
LYS
87
-69.86
91.52
11
A
GLU
98
-120.48
-58.50
11
A
VAL
119
-81.15
-111.13
12
A
LEU
69
-80.46
-78.39
12
A
ASP
77
57.87
107.07
12
A
ASN
78
39.48
81.85
13
A
LEU
69
-76.44
-72.44
13
A
SER
75
-150.53
-46.51
13
A
ASP
77
-68.07
-176.23
13
A
ASN
78
40.52
72.27
13
A
LYS
87
-69.36
87.75
13
A
GLU
98
-120.47
-52.90
13
A
VAL
119
-68.45
-101.99
14
A
ASP
71
-74.87
-169.93
14
A
ASP
77
43.02
95.13
14
A
ASN
78
61.18
96.38
14
A
ASN
94
-69.56
-168.05
14
A
ASN
96
-40.20
-70.06
14
A
VAL
119
-73.89
-110.71
15
A
ALA
74
-44.56
164.38
15
A
ASN
78
154.95
118.94
15
A
LYS
84
-62.38
-177.37
15
A
LYS
87
-68.52
84.25
15
A
ASN
94
-80.88
-156.85
15
A
ASN
96
-90.59
31.39
15
A
GLU
98
-122.51
-54.06
15
A
LYS
105
-36.87
-38.11
15
A
ASN
106
-146.86
53.18
16
A
ASP
77
-52.21
-176.21
16
A
ASN
78
-38.73
129.01
16
A
LYS
87
-67.39
82.19
16
A
ASN
94
-78.01
-87.96
16
A
HIS
95
163.07
38.70
16
A
ASN
96
174.28
39.26
16
A
LYS
105
-39.90
-33.67
16
A
ASN
106
-142.97
57.30
17
A
LEU
69
-91.28
-64.13
17
A
ALA
74
-57.57
90.34
17
A
ASN
78
39.90
65.74
17
A
GLU
98
-120.38
-51.76
17
A
VAL
119
-89.81
-110.07
18
A
LEU
69
-111.37
-81.54
18
A
ASP
77
174.70
-172.80
18
A
ASN
78
-56.01
88.74
18
A
LYS
84
-57.25
-179.78
18
A
HIS
95
85.23
80.92
18
A
ASN
96
170.94
-48.19
18
A
GLU
98
-120.32
-62.35
18
A
LYS
105
-39.75
-37.74
18
A
ASN
106
-150.29
34.93
19
A
LEU
69
-107.77
-74.32
19
A
ASN
94
-69.91
-161.83
19
A
ASN
96
172.17
-63.14
20
A
ASN
78
39.97
69.52
20
A
LYS
84
-62.21
-176.99
20
A
ASN
96
157.88
177.23
20
A
GLU
98
-120.72
-63.43
20
A
VAL
119
-76.66
-110.17
THE SOLUTION NMR STRUCTURE OF ABL SH3 AND ITS RELATIONSHIP TO SH2 IN THE SH(32) CONSTRUCT, 20 STRUCTURES
1
Y
N
KINASE
KINASE, SH3 DOMAIN, TRANSFERASE, PHOSPHOTRANSFERASE, PROTO-ONCOGENE, MULTIPLE DOMAIN, LEUKEMIA
ABL1_HUMAN
UNP
1
59
P00519
MLEICLKLVGCKSKKGLSSSSSCYLEEALQRPVASDFEPQGLSEAARWNSKENLLAGPSENDPNLFVALYDFVASGDNTL
SITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQ
RSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERT
DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTY
GNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAK
FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNP
SDRPSFAEIHQAFETMFQESSISDEVEKELGKQGVRGAVSTLLQAPELPTKTRTSRRAAEHRDTTDVPEMPHSKGQGESD
PLDHEPAVSPLLPRKERGPPEGGLNEDERLLPKDKKTNLFSALIKKKKKTAPTPPKRSSSFREMDGQPERRGAGEEEGRD
ISNGALAFTPLDTADPAKSPKPSNGAGVPNGALRESGGSGFRSPHLWKKSSTLTSSRLATGEEEGGGSSSKRFLRSCSAS
CVPHGAKDTEWRSVTLPRDLQSTGRQFDSSTFGGHKSEKPALPRKRAGENRSDQVTRGTVTPPPRLVKKNEEAADEVFKD
IMESSPGSSPPNLTPKPLRRQVTVAPASGLPHKEEAEKGSALGTPAAAEPVTPTSKAGSGAPGGTSKGPAEESRVRRHKH
SSESPGRDKGKLSRLKPAPPPPPAASAGKAGGKPSQSPSQEAAGEAVLGAKTKATSLVDAVNSDAAKPSQPGEGLKKPVL
PATPKPQSAKPSGTPISPAPVPSTLPSASSALAGDQPSSTAFIPLISTRVSLRKTRQPPERIASGAITKGVVLDSTEALC
LAISRNSEQMASHSAVLEAGKNLYTFCVSYVDSIQQMRNKFAFREAINKLENNLRELQICPATAGSGPAATQDFSKLLSS
VKEISDIVQR
65
119
1AWO
65
119
P00519
A
1
7
61
1
SER
conflict
GLY
59
1AWO
A
P00519
UNP
59
1
1
GLU
conflict
SER
60
1AWO
A
P00519
UNP
60
2
1
ASN
conflict
PRO
61
1AWO
A
P00519
UNP
61
3
1
ASP
conflict
GLY
62
1AWO
A
P00519
UNP
62
4
1
PRO
conflict
GLY
63
1AWO
A
P00519
UNP
63
5
1
ASN
conflict
SER
64
1AWO
A
P00519
UNP
64
6
1
ASN
conflict
SER
120
1AWO
A
P00519
UNP
120
62
2
3
anti-parallel
anti-parallel
anti-parallel
A
PHE
66
A
PHE
8
A
ALA
68
A
ALA
10
A
ILE
116
A
ILE
58
A
PRO
118
A
PRO
60
A
GLN
108
A
GLN
50
A
PRO
112
A
PRO
54
A
TRP
99
A
TRP
41
A
GLN
103
A
GLN
45
A
VAL
90
A
VAL
32
A
TYR
93
A
TYR
35
1
P 1